Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of Infection and Chemotherapy
Published in: Journal of Infection and Chemotherapy 4/2013

01-08-2013 | Case Report

Native-valve endocarditis caused by Mycobacterium chelonae, misidentified as polymicrobial gram-positive bacillus infection

Authors: Daisuke Takekoshi, Omar Al-Heeti, Patrick Belvitch, Dean E. Schraufnagel

Published in: Journal of Infection and Chemotherapy | Issue 4/2013

Login to get access

Abstract

Mycobacterium chelonae, a species of rapidly growing mycobacteria, may grow in routine blood culture media and stain as gram-positive bacilli, which may cause diagnostic confusion. A patient with native-valve endocarditis caused by M. chelonae, which was misidentified as various gram-positive bacilli, is presented.
Literature
1.
Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, ATS Mycobacterial Diseases Subcommittee, American Thoracic Society, Infectious Disease Society of America, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007;175:367–416.PubMedCrossRef
2.
Woods GL. Mycobacteria. In: McPherson RA, Pincus MR, editors. Henry’s clinical diagnosis and management by laboratory methods. 22nd ed. Philadelphia: Saunders; 2011. p. 1145–54.
3.
von Graevenitz A, Pünter-Streit V. Failure to recognize rapidly growing mycobacteria in a proficiency testing sample without specific request—a wider diagnostic problem? Eur J Epidemiol. 1998;14:519–20.CrossRef
4.
Williamson JC, Miano TA, Morgan MR, Palavecino EL. Fatal Mycobacterium abscessus endocarditis misidentified as Corynebacterium spp. Scand J Infect Dis. 2010;42:222–4.PubMedCrossRef
5.
De Groote MA, Huitt G. Infections due to rapidly growing mycobacteria. Clin Infect Dis. 2006;42:1756–63.PubMedCrossRef
6.
Wayne LG, Kubica GP. The mycobacteria. In: Sneath PA, Mair NS, Sharpe ME, Holt JG, editors. Bergey’s manual of systematic bacteriology, vol. 2. 1st ed. Baltimore: Williams & Wilkins; 1986. p. 1435–57.
7.
Larkin JA, Shashy RG, Gonzalez CA. Difficulties in differentiating a rapidly growing mycobacterium species from diphtheroids in an immunocompromised patient. Clin Microbiol Newsl. 1997;19:109–11.CrossRef
8.
Garg P, Athmanathan S, Rao GN. Mycobacterium chelonei masquerading as Corynebacterium in a case of infectious keratitis: a diagnostic dilemma. Cornea. 1998;17:230–2.PubMedCrossRef
9.
Grange JM. Mycobacterial infections following heart valve replacement. J Heart Valve Dis. 1992;1:102–9.PubMed
10.
Geraci JE, Anderson M, Karlson AG. Endocarditis due to a rapidly growing chromogenic mycobacterium. Mayo Clin Proc. 1968;43:124–33.PubMed
11.
Singh M, Bofinger A, Cave G, Boyle P. Mycobacterium fortuitum endocarditis in a patient with chronic renal failure on hemodialysis. Pathology. 1992;24:197–200.PubMedCrossRef
12.
Galil K, Thurer R, Glatter K, Barlam T. Disseminated Mycobacterium chelonae infection resulting in endocarditis. Clin Infect Dis. 1996;23:1322–3.PubMedCrossRef
13.
Kuruvila MT, Mathews P, Jesudason M, Ganesh A. Mycobacterium fortuitum endocarditis and meningitis after balloon mitral valvotomy. J Assoc Physicians India. 1999;47:1022–3.PubMed
14.
Spell DW, Szurgot JG, Greer RW, Brown JW 3rd. Native valve endocarditis due to Mycobacterium fortuitum biovar fortuitum: case report and review. Clin Infect Dis. 2000;30:605–6.PubMedCrossRef
15.
Liebeskind DS, Ostrzega N, Wasterlain CG, Buttner EA. Neurologic manifestations of disseminated infection with Mycobacterium abscessus. Neurology. 2001;56:810–3.PubMedCrossRef
16.
Collison SP, Trehan N. Native double-valve endocarditis by Mycobacterium fortuitum following percutaneous coronary intervention. J Heart Valve Dis. 2006;15:836–8.PubMed
17.
Corrales-Medina V, Concha R, Simkins J, Sanchez M, Baracco G. Native valve endocarditis caused by rapidly growing mycobacteria: case report and review of the literature. Scand J Infect Dis. 2007;39:639–41.PubMedCrossRef
18.
Tsai WC, Hsieh HC, Su HM, Lu PL, Lin TH, Sheu SH, Lai WT. Mycobacterium abscessus endocarditis: a case report and literature review. Kaohsiung J Med Sci. 2008;24:481–6.PubMedCrossRef
19.
Al-Benwan K, Ahmad S, Mokaddas E, Johny M, Kapoor MM. Diagnosis of endocarditis caused by Mycobacterium abscessus. Ann Saudi Med. 2010;30:408–11.PubMed
20.
Brown-Elliot BA, Wallance RJ. Infections due to nontuberculous mycobacteria other than Mycobacterium avium-intracellulare. In: Mandell GL, Bennett JE, Dolin R, editors. Mandell, Douglas, and Bennett’s principles and practice of infectious diseases. 7th ed. Philadelphia: Churchill Livingstone; 2010. p. 3191–98.
21.
Bonow RO, Carabello BA, Chatterjee K, de Leon AC Jr, Faxon DP, Freed MD, et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing Committee to Revise the 1998 guidelines for the management of patients with valvular heart disease) developed in collaboration with the Society of Cardiovascular Anesthesiologists endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. J Am Coll Cardiol 2006;48:e1–e148.
Metadata
Title
Native-valve endocarditis caused by Mycobacterium chelonae, misidentified as polymicrobial gram-positive bacillus infection
Authors
Daisuke Takekoshi
Omar Al-Heeti
Patrick Belvitch
Dean E. Schraufnagel
Publication date
01-08-2013
Publisher
Springer Japan
Published in
Journal of Infection and Chemotherapy / Issue 4/2013
Print ISSN: 1341-321X
Electronic ISSN: 1437-7780
DOI
https://doi.org/10.1007/s10156-012-0492-6

Other articles of this Issue 4/2013

Journal of Infection and Chemotherapy 4/2013 Go to the issue

Case Report

Complete response of esophageal small cell carcinoma amrubicin treatment

Note

In vitro antifungal drug susceptibilities of Penicillium marneffei from China

Original Article

Type IV pilus protein PilA of Pseudomonas aeruginosa modulates calcium signaling through binding the calcium-modulating cyclophilin ligand

Case Report

Testicular tuberculosis in multidrug-resistant pulmonary tuberculosis

Original Article

Variability of pharmacokinetic parameters in patients receiving different dosages of daptomycin: is therapeutic drug monitoring necessary?

Original Article

Evaluation of a new immunochromatographic assay for rapid identification of influenza A, B, and A(H1N1)2009 viruses
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits